Q2 Earnings Estimate for Liquidia Issued By HC Wainwright

Liquidia Co. (NASDAQ:LQDA - Free Report) - Investment analysts at HC Wainwright issued their Q2 2025 earnings estimates for shares of Liquidia in a note issued to investors on Thursday, March 20th. HC Wainwright analyst A. Fein forecasts that the company will post earnings per share of ($0.46) for the quarter. HC Wainwright currently has a "Buy" rating and a $29.00 target price on the stock. The consensus estimate for Liquidia's current full-year earnings is ($1.51) per share. HC Wainwright also issued estimates for Liquidia's Q3 2025 earnings at ($0.33) EPS, Q4 2025 earnings at ($0.25) EPS and FY2029 earnings at $0.51 EPS.

Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of ($0.38) by ($0.08). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The firm had revenue of $2.92 million during the quarter, compared to analyst estimates of $4.60 million.

A number of other equities research analysts also recently commented on LQDA. Wells Fargo & Company began coverage on Liquidia in a report on Friday, December 20th. They issued an "overweight" rating and a $20.00 target price for the company. Scotiabank increased their price target on shares of Liquidia from $30.00 to $34.00 and gave the company a "sector outperform" rating in a report on Thursday, March 20th. Finally, Needham & Company LLC boosted their price objective on shares of Liquidia from $19.00 to $25.00 and gave the stock a "buy" rating in a report on Thursday, March 20th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Liquidia currently has a consensus rating of "Buy" and an average target price of $26.63.

Remove Ads

Liquidia Trading Down 0.4 %

Shares of LQDA traded down $0.06 during mid-day trading on Friday, hitting $15.60. The company's stock had a trading volume of 676,229 shares, compared to its average volume of 933,021. Liquidia has a 1-year low of $8.26 and a 1-year high of $16.81. The firm has a market capitalization of $1.33 billion, a P/E ratio of -9.57 and a beta of 0.07. The firm has a 50-day simple moving average of $14.87 and a 200 day simple moving average of $12.27.

Insider Buying and Selling at Liquidia

In related news, CFO Michael Kaseta sold 23,370 shares of Liquidia stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total transaction of $275,298.60. Following the completion of the transaction, the chief financial officer now directly owns 401,755 shares in the company, valued at $4,732,673.90. The trade was a 5.50 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Rajeev Saggar sold 6,249 shares of the stock in a transaction on Tuesday, January 14th. The shares were sold at an average price of $11.78, for a total value of $73,613.22. Following the sale, the insider now owns 270,388 shares in the company, valued at approximately $3,185,170.64. This trade represents a 2.26 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 71,245 shares of company stock valued at $843,326 over the last quarter. Corporate insiders own 30.10% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. California State Teachers Retirement System boosted its stake in shares of Liquidia by 17.5% during the 4th quarter. California State Teachers Retirement System now owns 51,928 shares of the company's stock worth $611,000 after purchasing an additional 7,725 shares during the last quarter. Toronto Dominion Bank acquired a new stake in Liquidia during the fourth quarter worth approximately $235,000. Alpine Global Management LLC grew its stake in Liquidia by 50.0% in the 4th quarter. Alpine Global Management LLC now owns 150,000 shares of the company's stock worth $1,764,000 after acquiring an additional 50,000 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Liquidia by 26.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 105,734 shares of the company's stock valued at $1,243,000 after acquiring an additional 22,445 shares during the last quarter. Finally, Whitefort Capital Management LP lifted its stake in shares of Liquidia by 16.8% during the 4th quarter. Whitefort Capital Management LP now owns 1,987,245 shares of the company's stock worth $23,370,000 after purchasing an additional 285,220 shares during the period. Institutional investors and hedge funds own 64.54% of the company's stock.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).